SANUWAVE Health, Inc. SNWV Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by SANUWAVE Health, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The official record: SANUWAVE Health, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about SANUWAVE Health, Inc.'s cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is SANUWAVE Health, Inc.'s cash & equivalents?
- SANUWAVE Health, Inc. (SNWV) reported cash & equivalents of $10.78M in Q1 2026.
- How has SANUWAVE Health, Inc.'s cash & equivalents changed year-over-year?
- SANUWAVE Health, Inc.'s cash & equivalents increased by 26.8% year-over-year, from $8.5M to $10.78M.
- What is the long-term trend for SANUWAVE Health, Inc.'s cash & equivalents?
- Over 4 years (2021 to 2025), SANUWAVE Health, Inc.'s cash & equivalents has grown at a 109.7% compound annual growth rate (CAGR), from $619K to $11.96M.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.